Business Wire

NielsenIQ Connect Partner Network Expands Globally into Asia and Europe, Strengthening the Largest Open Ecosystem of Tech-driven Partners For Streamlining Data For The CPG Industry

Share

The NielsenIQ Connect Partner Network (CPN) has expanded its business globally into Asia and Europe, broadening the reach and influence of the network while also providing partners access to global data sets.

As the Consumer Packaged Goods (CPG) industry’s largest open ecosystem of tech-driven solution providers, the NielsenIQ Connect Partner Network has continued on its growth trajectory by selectively adding innovative partners since its launch in 2016. Now, by entering new markets, the network will expand its value to both clients and partners across the globe.

“The NielsenIQ Connect Partner Network is not only core to the success and growth of Nielsen, but also to the CPG industry as a whole”, said Johan Sjostrand, Global President Retail Intelligence, NielsenIQ. “In addition to the network expanding into global markets, it is also continuously growing by way of the number of member companies, as we recently surpassed 100 partners. We are able to continuously attract powerful partners because we never stop evolving our ways of working with them, and the opportunities and benefits provided to them. The network is a win for our clients, our partners, and NielsenIQ overall, which makes the network so unique and leads us to believe its influence will only expand from here.”

Partners are provided with streamlined access to industry-leading data, enabling them to enhance their own solutions. The diversity of markets that Asia and Europe encompass will provide unique opportunities and benefits to the CPG industry as a whole.

In a recent survey conducted by the NielsenIQ Connect Partner Network team, 83% of partners responded that the network has helped them create a stronger, better offering for their clients, while over 90% of partners said they were able to identify new opportunities due to their membership. NielsenIQ clients also benefit a great deal, as they can work directly with any of our partners who specialize across a broad range of areas including demand planning, data harmonization, machine learning, and AI-driven promotion, to name a few. With the NielsenIQ Connect Partner Network, clients and partners work with a common dataset, enabling them to easily bridge insights and save time typically spent figuring out who to work with, how to get data to who they decide to work with, and how to make sense of disparate data sources.

“We are extremely excited about the global expansion of NielsenIQ’s Connect Partner Network and what this means for us and our clients'', said Satish Raman, Chief Strategy Officer, Fractal Analytics. “One of the things we love most about the network is its openness, enabling us to freely and easily collaborate with NielsenIQ, our clients and other Connected Partners in the network. The opportunity to scale that collaboration globally will open more avenues to enter new markets, expand our client base, increase the depth and breadth of our engagements, and drive our solution and product enhancements. This is a profound step forward for the network and big news for NielsenIQ, but I also see this as big news for Fractal and all other partners, because any enhancement to the network will ultimately add value to us and our clients.”

“We are very proud of the success, expansion, and continued growth of the Network”, said Brett Jones, SVP, Global Leader, NielsenIQ Connect Partner Network. “Making this network truly global is a major milestone for us. It has always been our goal to evolve in a variety of ways, whether that be through the addition of new partners, the enhancement of our offerings, or entering new markets like we are now with Asia and Europe. There are even bigger things ahead for the Connected Partner Network as we never stop exploring avenues to positively impact the CPG landscape.”

For additional information, or if you are interested in becoming a NielsenIQ Connect Partner Network member, please go to https://www.nielsen.com/us/en/solutions/capabilities/connected-partner-program/. For a list of all partners please go to https://microsites.nielsen.com/connectedpartnernetwork/

ABOUT NIELSEN

Nielsen Holdings plc (NYSE: NLSN) is a global measurement and data analytics company that provides the most complete and trusted view available of consumers and markets worldwide. Nielsen is divided into two business units. Nielsen Global Media provides media and advertising industries with unbiased and reliable metrics that create a shared understanding of the industry required for markets to function. NielsenIQ (formerly known as Nielsen Global Connect) provides consumer packaged goods manufacturers and retailers with accurate, actionable information and insights and a complete picture of the complex and changing marketplace that companies need to innovate and grow.

Our approach marries proprietary Nielsen data with other data sources to help clients around the world understand what’s happening now, what’s happening next, and how to best act on this knowledge.

An S&P 500 company, Nielsen has operations in nearly 100 countries, covering more than 90% of the world’s population. For more information, visit www.nielsen.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Relations:
(Europe) Ekaterina Lukina (ekaterina.lukina@nielseniq.com)
(Asia) Sonya Cho (sonya.cho@nielseniq.com)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye